These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7883968)

  • 41. Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines.
    Mellish KJ; Kelland LR
    Cancer Res; 1994 Dec; 54(23):6194-200. PubMed ID: 7954466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
    Ekblad L; Kjellström J; Johnsson A
    Anticancer Drugs; 2010 Jun; 21(5):523-31. PubMed ID: 20168208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR; Wright KA; Mistry P; Kelland LR; Murrer BA
    Cancer Res; 1992 Oct; 52(20):5674-80. PubMed ID: 1327513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system.
    Dey S; Papadopoulou B; Haimeur A; Roy G; Grondin K; Dou D; Rosen BP; Ouellette M
    Mol Biochem Parasitol; 1994 Sep; 67(1):49-57. PubMed ID: 7838183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules.
    Christen RD; Jekunen AP; Jones JA; Thiebaut F; Shalinsky DR; Howell SB
    J Clin Invest; 1993 Jul; 92(1):431-40. PubMed ID: 8100837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Mann SC; Andrews PA; Howell SB
    Anticancer Res; 1988; 8(6):1211-5. PubMed ID: 3218956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance of in vitro grown IgM immunocytoma cells to cis-diamminedichloroplatinum (II) (cis-DDP) and cross-resistance to other DNA interacting drugs.
    Vendrik CP; de Jong WH; Van der Minnen AC; Fichtinger-Schepman AM; Steerenberg PA; Schornagel JH
    Anticancer Res; 1990; 10(2A):447-52. PubMed ID: 2346318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatin.
    Okuda T; Lin X; Trang J; Howell SB
    Mol Pharmacol; 2005 Jun; 67(6):1852-60. PubMed ID: 15758147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
    Kelland LR; Mistry P; Abel G; Loh SY; O'Neill CF; Murrer BA; Harrap KR
    Cancer Res; 1992 Jul; 52(14):3857-64. PubMed ID: 1617660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
    Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
    Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.
    Frühauf S; Zeller WJ
    Cancer Res; 1991 Jun; 51(11):2943-8. PubMed ID: 2032232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells.
    Andrews PA; Mann SC; Huynh HH; Albright KD
    Cancer Res; 1991 Jul; 51(14):3677-81. PubMed ID: 1648442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance.
    Papadopoulou B; Roy G; Dey S; Rosen BP; Ouellette M
    J Biol Chem; 1994 Apr; 269(16):11980-6. PubMed ID: 7909316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation.
    Salerno M; Petroutsa M; Garnier-Suillerot A
    J Bioenerg Biomembr; 2002 Apr; 34(2):135-45. PubMed ID: 12018890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line.
    Kimura E; Howell SB
    Cancer Chemother Pharmacol; 1993; 32(6):419-24. PubMed ID: 7903066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Mann SC; Andrews PA; Howell SB
    Cancer Chemother Pharmacol; 1990; 25(4):236-40. PubMed ID: 2295111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae.
    Haimeur A; Brochu C; Genest P; Papadopoulou B; Ouellette M
    Mol Biochem Parasitol; 2000 Apr; 108(1):131-5. PubMed ID: 10802326
    [No Abstract]   [Full Text] [Related]  

  • 58. Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1.
    Hemmingsson O; Nöjd M; Kao G; Naredi P
    Oncol Rep; 2009 Oct; 22(4):869-75. PubMed ID: 19724867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stable and inducible arsenite resistance in Chinese hamster cells.
    Wang Z; Rossman TG
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):80-6. PubMed ID: 8430428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of mammalian safety by incorporation of antimony potassium tartrate in zinc phosphide baits.
    Bai KM; Majumder SK
    Bull Environ Contam Toxicol; 1982 Jul; 29(1):107-14. PubMed ID: 7115988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.